Multi-Organ Microfluidic Platform for Accurate PK Profile Modeling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional microphysiological systems (MPS) for pharmacokinetic (PK) studies face limitations such as material adsorption of lipophilic compounds, low culture volumes affecting biological signal, lack of continuous sampling, and inadequate mathematical modeling for in vitro to in vivo translation, which hinder accurate representation of human PK profiles.
Innovation Solution
A method is developed to design a multi-organ construct platform by analyzing interactions between organ constructs, determining concentration profiles, and optimizing channel flow to replicate in-human PK profiles, incorporating continuous circulation and fluid shear stress to stimulate cellular responses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional microphysiological systems are used for PK studies, then the system structure is simple and easy to manufacture, but the material adsorbs lipophilic compounds and fails to accurately represent human PK profiles
Solution Approach 1:
The patent changes the material parameter of the device by using adsorption-resistant materials such as glass, cyclic olefin copolymer (COC), or cyclic olefin (COR) instead of conventional materials. This parameter change eliminates the harmful adsorption effect while maintaining the measurement function, thereby improving the accuracy of PK profile representation without compromising manufacturing simplicity.
2Measurement precision
If low culture volumes are used in MPS, then the device complexity is reduced and ease of manufacture is improved, but the biological signal is weakened
Solution Approach 1:
The patent applies local quality by creating distinct functional zones within the device: a high-density organ construct region that generates strong biological signals and a separate sampling/analysis region. This allows the system to maintain low overall culture volumes while concentrating biological activity in specific local areas, thereby preserving signal strength without increasing overall device complexity.
3Measurement precision
If conventional MPS are used without continuous sampling, then the device structure is simpler, but continuous monitoring of concentration profiles is not achieved
Solution Approach 1:
The patent implements continuous sampling through integrated microfluidic channels that continuously flow culture medium past the organ constructs and through detection zones. This continuous flow enables real-time monitoring of concentration profiles without requiring complex intermittent sampling mechanisms, thereby achieving continuous measurement precision while maintaining relatively simple device architecture.
4Measurement precision
If inadequate mathematical modeling is used, then the analysis process is simpler and faster, but in vitro to in vivo translation accuracy is reduced
Solution Approach 1:
The patent applies preliminary action by pre-calibrating the mathematical models with known physiological parameters and adsorption characteristics during the device design and validation phase. This preliminary modeling work establishes accurate baseline relationships between in vitro measurements and in vivo conditions, enabling rapid and accurate PK analysis without requiring complex real-time calculations, thus maintaining both translation accuracy and analysis speed.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enables more accurate in vitro PK analysis that translates better to in vivo results, facilitating faster and optimized PK studies with improved biological relevance and data richness across all platform compartments.
Implementation Method 1
flowing the molecular compound through the microfluidic device to cause the molecular compound to interact with the plurality of organ constructs
Implementation Method 2
incorporating continuous circulation and fluid shear stress to stimulate cellular responses
Data Source
AI summary
Microfluidic platforms including multiple microphysiological systems. At least one of the platforms include: at least one inlet; a plurality of organ constructs, each organ construct of the plurality of organ constructs being sized relative to other organ constructs of the plurality of organ constructs based on at least one predetermined human pharmacokinetic (PK) parameter; and a plurality of channels, each channel of the plurality of channels causing an organ construct of the plurality of organ constructs to be in fluidic communication with at least one other organ construct of the plurality of organ constructs.